Huawei launches wrist‑based blood pressure monitoring in the Watch D3 at ESC 2026, signaling a new entrant in the medical‑grade wearable market
Executive summary: Huawei introduced the Watch D3 smartwatch at ESC 2026, featuring cuff‑less wrist blood pressure measurement. It represents a potential shift toward continuous, non‑invasive blood pressure monitoring in consumer wearables, which could affect patient monitoring and market dynamics.
Who is involved: Huawei, the European Society of Cardiology (ESC), and medical‑device regulators overseeing wearable health claims.
Likely next: Independent clinical validation studies are expected in the next 6–12 months, followed by possible CE marking under MDR and commercial rollout in Europe.
At the European Society of Cardiology congress in Munich, Huawei unveiled the Watch D3, which claims to measure arterial blood pressure directly from the wrist without a cuff. The device leverages optical sensors and algorithmic processing to deliver readings comparable to traditional sphygmomanometers, according to the company’s presentation. If validated, the Watch D3 could expand Huawei’s presence in the health‑tech sector and intensify competition with established players such as Apple and Samsung. The announcement coincides with growing regulatory scrutiny of wearable health claims under the EU Medical Device Regulation.
Timeline
- — HUAWEI WATCH D3 debiutuje na Kongresie ESC 2026. Nowa era monitorowania ciśnienia tętniczego za pomocą pomiarow na nadgarstku (PR Newswire)
Analysis — what this means
Sectors affected
- Wearable health monitoring
- Consumer electronics
- Medical device manufacturing
Regulatory implications
- Must comply with EU Medical Device Regulation (MDR) Class IIa for wrist blood pressure devices, requiring clinical evaluation and post‑market surveillance.
Historical parallels
- Apple Watch Series 4 added ECG functionality in 2018 after FDA clearance.
- Samsung Galaxy Watch Active2 introduced cuff‑less blood pressure monitoring in 2020 following Korean MFDS approval.
Key entities
Sources
Open the full interactive case file on Beyond →